Telomere length predicts neutrophil recovery in the absence of G-CSF after autologous peripheral blood stem cell transplantation

被引:0
|
作者
L F Lincz
F E Scorgie
J A Sakoff
K A Fagan
S P Ackland
A Enno
机构
[1] Hunter Haematology Research Group,Medical Oncology Department
[2] Mater Misericordiae Hospital,undefined
[3] Mater Misericordiae Hospital,undefined
[4] Cytogenetics Unit,undefined
[5] Hunter Area Pathology Service,undefined
[6] Hunter Haematology Unit,undefined
[7] Hunter Area Pathology Service,undefined
来源
Bone Marrow Transplantation | 2004年 / 34卷
关键词
telomere; haemopoietic recovery; G-CSF; autologous peripheral blood stem cell transplantation;
D O I
暂无
中图分类号
学科分类号
摘要
Haemopoietic regeneration after autologous peripheral blood progenitor cell (PBPC) transplantation can be delayed in some patients despite adequate infusion of CD34+ cells. This suggests variability in the proliferation potential of the implanted cells, a capacity that may be predicted by their telomere length. To test this theory, telomere length was measured on stored apheresis samples from 36 patients aged 46.6±11.1 years, who had undergone successful autologous PBPC transplantation with a median of 5.6 × 106/kg (1.3 × 106–36.1 × 106/kg) CD34+ cells. The mean PBPC telomere length for the cohort was 9.4±2.3 kbp. For patients who did not receive G-CSF post transplantation (n=7), days to absolute neutrophil recovery (ANC), ⩾0.1, 0.5 and 1.0 × 109 cells/l, were significantly inversely correlated with telomere length of the infused PBPC (r=−0.88, −0.81, −0.77, respectively; P<0.05,). However, no correlation was found for patients who received G-CSF from day 1 post transplantation (n=20). These data suggest that for transplantation with sufficient CD34+ cells, neutrophil recovery is less efficient in patients receiving infusions of cells with short telomeres, but this deficiency can be corrected with adequate post transplantation administration of G-CSF.
引用
收藏
页码:439 / 445
页数:6
相关论文
共 50 条
  • [31] Superior antileukemic activity of murine peripheral blood progenitor cell (PBPC) grafts mobilized by G-CSF and stem cell factor (SCF) as compared to G-CSF alone
    Hartung, G
    Uharek, L
    Zeis, M
    Glass, B
    Steinmann, J
    Dreger, P
    Krönke, M
    Schmitz, N
    BONE MARROW TRANSPLANTATION, 1998, 21 : S16 - S20
  • [32] Late autologous transplantation in chronic myelogenous leukemia with peripheral blood progenitor cells mobilized by G-CSF and interferon-α
    M Michallet
    A Thiébaut
    I Philip
    C Charrin
    C Vigouroux
    X Thomas
    K Bilger
    A Belhabri
    D Guyotat
    B Corront
    B Salles
    C Dumontet
    PY Péaud
    JP Vilque
    A Devidas
    D Fière
    Leukemia, 2000, 14 : 2064 - 2069
  • [33] A prospective randomized study of clinical and economic consequences of using G-CSF following autologous peripheral blood progenitor cell (PBPC) transplantation in children
    M González-Vicent
    L Madero
    J Sevilla
    M Ramirez
    M A Díaz
    Bone Marrow Transplantation, 2004, 34 : 1077 - 1081
  • [34] A prospective randomized study of clinical and economic consequences of using G-CSF following autologous peripheral blood progenitor cell (PBPC) transplantation in children
    González-Vicent, M
    Madero, L
    Sevilla, J
    Ramirez, M
    Díaz, MA
    BONE MARROW TRANSPLANTATION, 2004, 34 (12) : 1077 - 1081
  • [35] Randomized comparison of G-CSF+GM-CSF vs G-CSF alone for mobilization of peripheral blood stem cells: effects on hematopoietic recovery after high-dose chemotherapy
    Spitzer, G
    Adkins, D
    Mathews, M
    Velasquez, W
    Bowers, C
    Dunphy, F
    Kronmueller, N
    Niemeyer, R
    McIntyre, W
    Petruska, P
    BONE MARROW TRANSPLANTATION, 1997, 20 (11) : 921 - 930
  • [36] Use of concurrent G-CSF + GM-CSF vs G-CSF alone for mobilization of peripheral blood stem cells in children with malignant disease
    L Madero
    M González-Vicent
    J Molina
    R Madero
    V Quintero
    MA Díaz
    Bone Marrow Transplantation, 2000, 26 : 365 - 369
  • [37] G-CSF AFTER AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR MALIGNANT DISEASES IN CHILDREN
    MADERO, L
    MUNOZ, A
    DEHEREDIA, AD
    MARTINEZ, A
    BADELL, I
    ESQUEMBRE, C
    RAMIREZ, M
    OTHEO, E
    OLIVE, A
    SASTRE, A
    PARDO, N
    CASTELL, V
    BONE MARROW TRANSPLANTATION, 1995, 15 (03) : 349 - 351
  • [38] Splenic Rupture in a Plasma Cell Leukemia, Mobilized with G-CSF for Autologous Stem Cell Transplant
    Funes, Consuelo
    Garcia-Candel, Faustino
    Majado, Maria Juliana
    Gonzalez-Garcia, Consuelo
    Bas, Agueda
    Salido, Eduardo
    Moraleda, Jose M.
    Morales, Alfonso
    JOURNAL OF CLINICAL APHERESIS, 2010, 25 (04) : 223 - 225
  • [39] Mobilization of peripheral blood stem cells in children using G-CSF after carboplatin containing myelosuppressive chemotherapy
    Rauck, AM
    Ruymann, FB
    Klopfenstein, K
    Grossman, N
    Rosselet, R
    Grovas, L
    Ceselski, S
    Hayes, J
    Grovas, AC
    JOURNAL OF CLINICAL APHERESIS, 1998, 13 (04) : 146 - 154
  • [40] Adverse side-effects associated with G-CSF in patients with chronic myeloid leukemia undergoing allogeneic peripheral blood stem cell transplantation
    Khoury, H
    Adkins, D
    Brown, R
    Vij, R
    Westervelt, P
    Trinkaus, K
    Goodnough, LT
    DiPersio, JF
    BONE MARROW TRANSPLANTATION, 2000, 25 (11) : 1197 - 1201